We are pleased to announce a new poster presentation entitled “Evaluation of a commercial assay whole genome HIV-1 using next-generation sequencing” at ECCMID 2022.

Link to the poster presentation.

Please feel free to contact us to get more information.

ABL DIAGNOSTICS S.A.

42, rue Olivier Métra – Bat E1

75020, PARIS FRANCE

Phone : +33 145 061 574

Email :

contact@abldiagnostics.com

Email 2 :

fauvet-girel@ablsa.com

Scroll to Top